exploring the combination of epacadostat and pembrolizumab in urothelial carcinoma
Published 6 years ago • 283 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:36
pembrolizumab in urothelial cancer
-
1:05
dr. petrylak on combinations with pembrolizumab in urothelial carcinoma
-
1:18
dr. plimack on combo of pembrolizumab/epacodostat in bladder cancer
-
3:45
fierce-22 trial: vofatamab with pembrolizumab for urothelial carcinoma
-
1:08
dr. james l. gulley on atezolizumab, pembrolizumab, and avelumab's potential uses in bladder cancer
-
2:43
pembrolizumab: defining standards of care in urothelial cancer
-
1:09
dr. plimack on frontline pembrolizumab for urothelial carcinoma
-
1:34
dr. garcia on fda approval of pembrolizumab in bladder cancer
-
0:47
expert highlights next steps to evolve the treatment landscape of urothelial cancer
-
1:45
pembrosarc: pembrolizumab combinations for advanced sarcoma
-
1:22
key clinical trials in urothelial carcinoma at esmo 2021
-
3:35
keynote-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma
-
42:29
advanced melanoma
-
2:21
phase 2 pivotal trial of padcev in advanced urothelial cancer
-
1:36
avelumab and pembrolizumab for the treatment of merkel cell carcinoma
-
1:07
clinical update on the current management of advanced urothelial bladder cancer (short)
-
1:19
dr. rini on the efficacy of axitinib and pembrolizumab in rcc
-
52:35
using the case study of atezolizumab development to rethink early phase oncology trial design
-
1:06
dr. daniel petrylak on early trials for a new urothelial bladder cancer treatment